Last updated on October 2016

A study of rHIgM22 dosage in relapsing MS patients.


Other Details:

Qualified participants receive study-related medical care and study medication or placebo at no cost and may be compensated for time and travel.



Find a site near you

Start Over

Collaborative Neuro Science Network

2600 Redondo Avenue, Suite 500 Long Beach, CA USA
  Connect »

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Volunteer Sign-up

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.